Paramagnetic rim lesions are associated with pathogenic CSF profiles and worse clinical status in multiple sclerosis:

Christopher C Hemond1, Jonggyu Baek2, Carolina Ionete3

  • 1Department of Neurology, University of Massachusetts Chan Medical Center and University of Massachusetts Chan Medical School, Worcester, MA, USA.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|June 24, 2022
PubMed
Abstract

Insights

Paramagnetic rim lesions (PRLs) in multiple sclerosis (MS) are linked to increased disease severity and blood-brain barrier disruption. These findings highlight PRLs as potential biomarkers for chronic neuroinflammation in MS patients.

Area of Science:

  • Neuroimaging
  • Neurology
  • Immunology

Background:

  • Paramagnetic rim lesions (PRLs) are observed in multiple sclerosis (MS) lesions using susceptibility-sensitive MRI.
  • PRLs indicate compartmentalized inflammation within MS lesions.

Purpose of the Study:

  • To investigate clinical, MRI, and intrathecal (cerebrospinal fluid, CSF) associations of paramagnetic rim lesions (PRLs) in MS.
  • Utilize 3T MRI for enhanced detection and characterization of PRLs.

Main Methods:

  • Retrospective, cross-sectional analysis of 147 MS patients.
  • 3T MRI with T2*-weighted sequence and susceptibility postprocessing (SWAN protocol).
  • Manual review of SWAN-filtered phase maps and T2-FLAIR images to identify PRLs; statistical analyses for associations.

Main Results:

  • 43% of MS patients exhibited at least one PRL.
  • PRL presence associated with younger age, shorter disease duration, worse disease severity, high-efficacy therapy use, poorer dexterity, reduced brain volumes, and slower cognitive processing speeds.
  • PRL status correlated with blood-brain barrier disruption, indicated by elevated albumin quotient.

Conclusions:

  • PRLs are confirmed noninvasive biomarkers of chronic neuroinflammation in MS.
  • PRLs are associated with greater disease severity and preliminary evidence suggests a link to blood-brain barrier disruption.